TABLE 3.
Interobserver concordance. [Copyright: ©2013 Börve et al.]
FTF vs TD 1* | FTF vs TD 2* | TD 1 vs TD 2* | ||||
---|---|---|---|---|---|---|
Diagnostic level | IOC (95% CI)* | κ* | IOC (95% CI)* | κ* | IOC (95% CI)* | κ* |
Primary diagnosis | 55% (43–67%) | 0.47 | 57% (44–68%) | 0.48 | 58% (45–70%) | 0.51 |
Benign vs malignant | 77% (65–86%) | 0.50 | 78% (67–87%) | 0.50 | 78% (67–87%) | 0.49 |
Melanocytic vs non-melanocytic | 88% (78–95%) | 0.77 | 91% (82–97%) | 0.82 | 88% (78–95%) | 0.77 |
Combination** | 71% (59–81%) | 0.60 | 72% (60–83%) | 0.61 | 71% (59–81%) | 0.59 |
FTF, face-to-face dermatologist; TD 1, teledermoscopist 1; TD 2, teledermoscopist 2; IOC, interobserver concordance; CI, confidence interval; κ, kappa value.
Combination of correct classification as benign or malignant and melanocytic or non-melanocytic.